The Impact of Continuous Infusion of Remifentanil and Remimazole on Postoperative Cough in Patients Undergoing Nasal Surgery

Effect of remifentanil on the emergence cough from remimazolam anesthesia in nasal surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009193

Enrollment

Registered

2024-02-21

Start date

2022-12-29

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : After preoxygenation with 100% oxygen for 1 minute, patients received a continuous infusion of remimazolam at a rate of 12 mg/kg/hr. Simultaneously, using a Target-Controlled Infusion (TCI) dev

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 19-65 years, classified as ASA physical status I or II, undergoing endoscopic sinus surgery and septoplasty under general anesthesia

Exclusion criteria

Exclusion criteria: Conditions indicating difficult airway management (Mallampati=3), chronic obstructive pulmonary disease, bronchial asthma, severe cardiac, renal, and hepatic diseases

Design outcomes

Primary

Measure	Time frame
The frequecny of emergence coguh	—

Secondary

Measure	Time frame
The severity of emergence cough;Bloodp pressure after extubation;Heart rate after extubation;postoperative nausea and vomiting in PACU;adverse event	—

Countries

Korea, Republic of

Contacts

Public ContactSoo Jung Park

Ajou University Hospital

llssooll@aumc.ac.kr+82-31-219-4917

Outcome results